Best treatments for proteinuria
2 products may treat proteinuria, spanning FDA drug classes such as angiotensin 2 receptor blocker, endothelin receptor antagonist. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 2 drugs we list for proteinuria, none are yet flagged as generics in our price data, spanning classes such as angiotensin 2 receptor blocker, endothelin receptor antagonist. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for proteinuria — so confirm the right choice with your prescriber.
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | Not yet rated | Prescription | Tablet | Angiotensin 2 Receptor Blocker | No data | — | View → | |
| 2 | Not yet rated | Prescription | Injectable | — | No data | — | View → |
Full ranking · 2 treatments
filspari
Boxed warningPrescriptionFDA-sourced
Filspari (Sparsentan) is an angiotensin 2 receptor blocker used to treat Proteinuria.
Price varies
voyxact
PrescriptionFDA-sourced
Voyxact (Sibeprenlimab-Szsi) is a medication used to treat Iga Glomerulonephritis, Proteinuria.
Price varies
Frequently asked
- What treats proteinuria?
- Our catalog lists 2 products that may treat proteinuria, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists.
- What is the best-rated treatment for proteinuria?
- Ratings appear as FDA recall-safety data accumulates for the products that may treat proteinuria.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat proteinuria?
- Treatments for proteinuria span FDA drug classes including angiotensin 2 receptor blocker, endothelin receptor antagonist. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.